NCT02003508View on ClinicalTrials.gov

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination

CompletedOBSERVATIONAL
Enrollment

345

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 29, 2017

Study Completion Date

December 29, 2017

Conditions
Human Papillomavirus
Trial Locations (1)

3053

Melbourne Sexual Health Centre, Melbourne

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

The Alfred

OTHER

NCT02003508 - Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination | Biotech Hunter | Biotech Hunter